SDS Biotech KK (4952)

Tokyo

Currency in JPY

1,436.0

0.0(0.00%)

Closed·28/07

Day's Range

1,436.0

1,438.0

52 wk Range

1,436.0

1,438.0

4952 Income Statement

Featured here, the Income Statement (earnings report) for SDS Biotech KK, showing the company's financial performance from operating and non operating activities such as revenue, expenses and income for the last 4 periods (either quarterly or annually).

Period Ending:

1999

31/12

2007

31/12

2008

31/12

2009

31/12

2010

31/12

2013

31/12

2014

31/12

2015

31/12

2016

31/03

2017

31/03

Total Revenues

aa.aa

13,034

15,740

16,719

17,116

14,988

Total Revenues Growth

aa.aa

+14.05%

+20.76%

+6.22%

+2.37%

-12.43%

Cost of Revenue

aa.aa

8,090

9,929

10,688

11,068

9,967

Gross Profit

aa.aa

4,944

5,811

6,031

6,048

5,021

Gross Profit Growth

aa.aa

+9.3%

+17.54%

+3.79%

+0.28%

-16.98%

Gross Profit Margin %

aa.aa

37.93%

36.92%

36.07%

35.34%

33.5%

Other Operating Expenses, Total

aa.aa

3,815

4,246

4,393

4,556

4,286

	Other Operating Expenses, Total Growth
	R&D Expenses
	Selling General & Admin Expenses
	Other Operating Expenses

aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	+20.9%	+11.3%	+3.46%	+3.71%	-5.93%
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-	965	-	1,169	1,095
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	3,609	3,067	4,393	3,125	3,017
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-	-	-	-	-

Operating Income

aa.aa

1,129

1,565

1,638

1,492

735

Operating Income Growth

aa.aa

-17.46%

+38.62%

+4.66%

-8.91%

-50.74%

EBIT Margin %

aa.aa

8.66%

9.94%

9.8%

8.72%

4.9%

Net Interest Expenses

aa.aa

-157

-261

-406

-416

-337

Net Interest Expenses Growth

aa.aa

-67.78%

-66.24%

-55.56%

-2.46%

+18.99%

Interest Expense, Total

aa.aa

-158

-268

-415

-426

-352

Interest And Investment Income

aa.aa

Other Non Operating Expenses, Total

aa.aa

110

144

165

EBT, Excl. Unusual Items

aa.aa

1,008

1,386

1,342

1,679

563

Gain (Loss) On Sale Of Assets

aa.aa

-5

-1

Other Unusual Items, Total

aa.aa

-6

-19

-22

-787

EBT, Incl. Unusual Items

aa.aa

1,008

1,375

1,324

1,199

-225

EBT, Incl. Unusual Items Growth

aa.aa

-16.57%

+36.41%

-3.71%

-9.44%

-118.77%

EBT, Incl. Unusual Items Margin

aa.aa

7.73%

8.74%

7.92%

7.01%

-1.5%

Income Tax Expense

aa.aa

330

504

485

474

139

Net Income to Company

aa.aa

678

871

839

725

-364

Minority Interest

aa.aa

-36

-58

105

155

161

Net Income

aa.aa

642

813

944

880

-203

Net Income Growth

aa.aa

-19.32%

+26.64%

+16.11%

-6.78%

-123.07%

Net Income Margin %

aa.aa

4.93%

5.17%

5.65%

5.14%

-1.35%

Preferred Dividend and Other Adjustments

aa.aa

Net Income to Common Excl. Extra Items

aa.aa

642

813

944

880

-203

Basic EPS - Continuing Operations

aa.aa

82.14

103.83

120.56

112.39

-25.93

Basic EPS - Continuing Operations Growth

aa.aa

-19.47%

+26.41%

+16.11%

-6.78%

-123.07%

Diluted EPS - Continuing Operations

aa.aa

82.14

103.83

120.56

112.39

-25.93

Diluted EPS - Continuing Operations Growth

aa.aa

-19.42%

+26.41%

+16.11%

-6.78%

-123.07%

Basic Weighted Average Shares Outstanding

aa.aa

7.82

7.83

Diluted Weighted Average Shares Outstanding

aa.aa

7.82

7.83

Dividend Per Share

aa.aa

Dividend Per Share Growth

aa.aa

+25%

EBITDA

aa.aa

1,598

2,045

2,119

1,966.4

1,180

EBITDA Growth

aa.aa

-7.62%

+27.97%

+3.62%

-7.2%

-39.99%

EBITDA Margin %

aa.aa

12.26%

12.99%

12.67%

11.49%

7.87%

EBIT

aa.aa

1,129

1,565

1,638

2,023

735

* In Millions of JPY (except for per share items)

Nifty 50

24,989.95

-122.45

-0.49%

BSE Sensex

82,084.79

-323.38

-0.39%

Nifty Bank

56,051.85

-201.00

-0.36%

Nifty 50 Futures

25,009.00

-102.70

-0.41%

US 500

5,982.70

+14.9

+0.25%

FTSE 100

8,774.16

-0.49

-0.01%

Dollar Index

98.77

+0.488

+0.50%

Market Movers

Name	Last	Chg. %	Vol.
Zee Entertainment	146.63	+10.18%	109.58M
Bharat Electronics	421.00	+3.12%	35.85M
BSE	2,775.00	+3.23%	5.68M
Garden Reach	3,497.80	+6.39%	3.95M
BEML	4,811.00	+3.70%	2.58M
Trent	6,159.50	+4.44%	1.87M
Dixon Tech	14,552.00	+3.53%	1.73M

Name	Last	Chg. %	Vol.
Lakshmi Mills	8,635.85	+20.00%	2.86K
Tamilnadu Telecomm	11.760	+20.00%	441.12K
JMJ Fintech	40.10	+19.99%	102.21K
Kerala Ayurveda	511.70	+19.99%	2.92M
Parmax Pharma	38.02	+19.97%	22.22K
Silver Pearl Hospitality Luxury	10.55	+19.61%	8.00K
Informed Tech India	78.34	+18.73%	4.91K

Name	Last	Chg. %	Vol.
Paramatrix Tech	85.05	-12.45%	1.20K
Osia Hyper	18.00	-10.04%	1.37M
SBL Infratech	36.81	-10.00%	2.40K
Naapbooks	126.85	-9.97%	1.20K
Fabino Life Sciences	31.50	-9.22%	15.00K
Catvision Ltd	21.70	-8.25%	24.99K
Munjal Showa Ltd	122.60	-7.66%	785.22K

Trending Stocks

Name	Last	Chg. %	Vol.
Bharat Electronics	421.05	+3.14%	35.74M
HDFC Bank	1,947.00	-0.90%	4.33M
Reliance Industries	1,456.80	-0.64%	4.81M
BSE	2,779.00	+3.38%	5.67M
Zee Entertainment	146.62	+10.17%	109.39M

Most Undervalued Stocks

Name	Last	Upside	Fair Value
Aaaaaa Aaaaa	407.25	+46.42%	596.30
Aaaaaaaaaaa Aaaa	194.34	+45.23%	282.24
A Aa Aaaaaaaaaa	62.98	+43.63%	90.46
Aaaaa A	869.00	+37.72%	1,196.79
Aaaa Aaaaaaaaa	869.85	+37.68%	1,197.61
Aaaaa	111.12	+37.51%	152.80
Aaaaaaaaa Aaaaaaaa	554.35	+37.42%	761.79

Name	Last	Upside	Fair Value
Aaaaaa Aaaaa	407.25	+46.42%	596.30
Aaaaaaaaaaa Aaaa	194.34	+45.23%	282.24
A Aa Aaaaaaaaaa	62.98	+43.63%	90.46
Aaaaa A	869.00	+37.72%	1,196.79
Aaaa Aaaaaaaaa	869.85	+37.68%	1,197.61
Aaaaa	111.12	+37.51%	152.80
Aaaaaaaaa Aaaaaaaa	554.35	+37.42%	761.79

See full list

Install Our AppScan QR code to install app

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

Popular Searches

Please try another search

SDS Biotech KK (4952)

4952 Income Statement

Trending Stocks